Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Single-use device reuse

This article was originally published in The Gray Sheet

Executive Summary

House-Senate conferees agree to language in the FY 2000 agriculture appropriations bill that would require FDA to allocate $1 mil. to study the reprocessing of single-use medical devices, conferee Sen. Richard Durbin (D-Ill.) reports Sept. 23. The provision was a part of the Senate ag approps measure but Durbin notes that conferees opted to use language from his stand-alone bill (S 1542), the "Reprocessed Single Use Medical Device Patient Safety Amendments," rather than what originally had been proposed. The conference committee has also agreed to set FDA appropriations at approximately $1.19 bil. -below the level approved by the House but above that passed by the Senate. The conference committee has stood in recess since Sept. 22, stalled by disagreements over agricultural issues. No date has been set for resuming the conference

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel